Delivery Order SPE2DB22D3011-SPE2DB25FQ2VR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $4,509.24. This is a firm fixed price, non-set-aside competitively awarded contract with an ultimate completion date of August 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $2,134.71 and an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of the company's...
- The Defense Logistics Agency awarded a $6,809.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Adapalene 0.1% Cream in 45-gram quantities, with an ultimate completion date of September 11, 2025. The award, issued on September 10, 2025, carries no set-aside designation and represents a competitively awarded contract. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $1,241.06 and a firm fixed price structure. This non-set-aside contract is set for completion by August 15, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,044.76 to AmerisourceBergen Drug Corp for the supply of Adapalene 0.1% cream in 45-gram quantities. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, awarded on September 10, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adapalene 0.1% Cream (45GM) with a ceiling value of $2,118.00 under a firm fixed price contract type. The award was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,693.65 to AmerisourceBergen Drug Corp for the supply of Adapalene 0.1% Cream in 45-gram quantities. This competitively awarded, firm fixed-price delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $5,044.01 to AmerisourceBergen Drug Corp for Adapalene 0.1% cream on August 27, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 20, 2025, for Adapalene 0.1% Cream in 45-gram quantities. The contract is valued at $1,423.93 under a firm fixed price structure with an ultimate completion date of August 21, 2025. This award represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 12, 2025, for Adapalene 0.1% cream in a 1-ounce formulation under a firm fixed-price contract valued at $11,269.53. The award was made without a set-aside designation and carries an ultimate completion date of September 9, 2025. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which is valued at...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2VRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Adapalene 0.1% Cream in 45-gram quantities, with a ceiling value of $2,982.42 and a completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.9 million and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical procurement requirements, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Performance of this delivery order will occur at the company's Conshohocken facility, with the product supporting the Defense Health Agency and other government healthcare systems through the DLA's flexible and comprehensive contract structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/19/25 |